A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases
Status:
Completed
Trial end date:
2011-11-24
Target enrollment:
Participant gender:
Summary
The main purpose of the study is to see how safe SRT3025 (study drug) is when given at
different doses. The study will also investigate how the study drug is taken up, metabolised
(chemically broken down), distributed through the body and excreted. A further aim is to look
at how taking the study drug after eating might change this process.